[1]
“ Overview about pharmacoeconomics analysis and burden-of-illness in schizophrenia ”, Arch Clin Psychiatry (former: Rev Psiq Clin), vol. 34, no. supl.2, pp. 208–212, Jan. 2007, doi: 10.1590/S0101-60832007000800012.